Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 16761 - 16780 out of 566296 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01BC07) azacitidine | Azacitidine (SXP) 100 mg powder for injection, 1 vial | Powder for injection 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SouthernXPPtyLtd |
| Australia | (L01BC07) azacitidine | Azacitidine (SXP) 100 mg powder for injection, 1 vial | Powder for injection 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SouthernXPPtyLtd |
| Australia | (L01BC07) azacitidine | Azacitidine (SXP) 100 mg powder for injection, 1 vial | Powder for injection 100 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SouthernXPPtyLtd |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 10 mg tablet, 56 | Tablet 10 mg, 56 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 10 mg tablet, 56 | Tablet 10 mg, 56 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 44 mg/1.1 mL injection, 1.1 mL vial | Solution for subcutaneous injection 44 mg in 1.1 mL (40 mg per mL), 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 76 mg/1.9 mL injection, 1.9 mL vial | Solution for subcutaneous injection 76 mg in 1.9 mL (40 mg per mL), 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L03AA13) pegfilgrastim (adm: P) | Pelgraz 6 mg/0.6 mL injection, 0.6 mL syringe | Injection 6 mg in 0.6 mL single use pre-filled syringe, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcarePty.Ltd. |
| Australia | (L03AA13) pegfilgrastim (adm: P) | Ziextenzo 6 mg/0.6 mL injection, 0.6 mL syringe | Injection 6 mg in 0.6 mL single use pre-filled syringe, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SandozPtyLtd |
| Australia | (L03AB11) peginterferon alfa-2a (adm: P) | Pegasys 135 microgram/0.5 mL injection, 4 x 0.5 mL syringes | Injection 135 micrograms in 0.5 mL single use pre-filled syringe, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic;Hepatitis B, Chronic;Polycythemia Vera;Thrombocythemia, Essential | EchoTherapeuticsPtyLtd |
Pages
